David discusses the promising potential of NAD supplements, particularly NMN, in treating energy-deficient diseases like Friedrich's ataxia. He emphasizes the importance of cautious research and transparency, distancing himself from companies that misuse his name. With a focus on unbiased information, he shares insights on navigating the supplement landscape while maintaining scientific integrity.
